[Clinical studies on cefpodoxime proxetil in the pediatric fields]. 1989

A Watanabe, and M Koshinami
Department of Pediatrics, Aomori Prefectural Central Hospital.

Cefpodoxime proxetil (CPDX-PR, CS-807) was given orally to 18 children with acute bacterial infections including 10 with acute tonsillitis, 3 with acute bronchitis, 1 with pneumonia, 3 with staphylococcal scalded skin syndrome and 1 with infectious impetigo. Daily dosages per kg bodyweight ranging from 7.5 to 18 mg were given in 2 or 3 divided doses per day for 5 to 15 days. Clinical responses were excellent in 3 (16.7%), good in 11 (61.1%), fair in 4 (22.2%) and poor in 0 (0%), with an overall efficacy rate of 77.8%. Good bacteriological responses were obtained in 6 out of the 7 cases from which pathogens were identified. No side effect was observed. The above results suggest that CPDX-PR is a useful new oral cephalosporin derivative for the treatment of bacterial infections in children.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097627 Cefpodoxime Proxetil A prodrug of its active metabolite CEFPODOXIME. 1-(Isopropoxycarbonyloxy)ethyl-7-(2-(2-Amino-4-thiazolyl)-2-(Methoxyimino)Acetamido)-3-Methoxymethyl-8-oxo-5-thia-1-Azabicyclo(4,2,0)-oct-2-ene-2-Carboxylate,Cephalosporin 807,Orelox,Otreon,U-76252,CS 807,CS-807,U 76252,Vantin,76252, U,807, CS,807, Cephalosporin,Proxetil, Cefpodoxime,U76252

Related Publications

A Watanabe, and M Koshinami
July 1989, The Japanese journal of antibiotics,
A Watanabe, and M Koshinami
July 1989, The Japanese journal of antibiotics,
A Watanabe, and M Koshinami
July 1989, The Japanese journal of antibiotics,
A Watanabe, and M Koshinami
July 1989, The Japanese journal of antibiotics,
A Watanabe, and M Koshinami
July 1989, The Japanese journal of antibiotics,
A Watanabe, and M Koshinami
July 1989, The Japanese journal of antibiotics,
A Watanabe, and M Koshinami
October 1988, The Japanese journal of antibiotics,
A Watanabe, and M Koshinami
July 1989, The Japanese journal of antibiotics,
A Watanabe, and M Koshinami
July 1989, The Japanese journal of antibiotics,
A Watanabe, and M Koshinami
January 2019, Profiles of drug substances, excipients, and related methodology,
Copied contents to your clipboard!